USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
United States Liquid Biopsy Growth Opportunities
Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape
22-Feb-2022
North America
Market Research
K695-01-00-00-00
HC03509-NA-MT_26295
Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio.
Advances in next-generation sequencing-based companion diagnostics (CDx) and liquid biopsy (LBx) enable precision medicine approaches toward diseases such as cancer. Another aspect changing the diagnostics industry is linking automation to digital technologies to improve efficiency and productivity. This includes leveraging artificial intelligence to enhance workflow and accuracy.
Frost & Sullivan’s analysis shows that the top 5 companies in the US liquid biopsy market—Exact Sciences, Guardant Health, Roche/Foundation Medicine, Natera, and LabCorp—account for 77.5% of its revenue in 2020. We expect the market to reach $7.02 billion by 2025 at a 14% CAGR.
The report provides updates on the competitive landscape by analyzing market dynamics, participants, and investments. It also offers stakeholders insights through forecasts, analysis by therapy (oncology and non-oncology) and product type (kits and reagents, instruments and analysis platforms, testing and development services), and growth opportunities.
Author: Amol Dilip Jadhav
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top Three Strategic Imperatives on the Liquid Biopsy Market
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Segmentation by Therapy
Segmentation by Product Type
Key Competitors by Product Type and Therapy
Terminologies
Major cfNA Analysis Methods are PCR- or NGS-based
Review of Liquid Biopsy Applications by Analytes in Cancer
cfNA Diagnostics Applications across the Cancer Care Continuum
Key Growth Metrics
Growth Drivers
Growth Restraints
Regulatory Landscape
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Therapy
Revenue Forecast by Oncology Product/Service Type
Revenue Forecast by NIPT Product/Service Type
Revenue Forecast for Other Products/Services
Revenue Forecast Analysis
Revenue Forecast Analysis by Selected Products/Services
Revenue Forecast Analysis by Therapy
Competitive Environment
Revenue Share
Revenue Share—Oncology Therapy
Revenue Share—NIPT Therapy
Revenue Share Analysis
Key Growth Metrics
Revenue Forecast—Oncology Therapy
Revenue Forecast Analysis—Oncology Therapy
Key Growth Metrics
Revenue Forecast—Non-oncology Therapy
Revenue Forecast Analysis—Non-oncology Therapy
Competitive Ecosystem
Competitor Matrix
Competitor Matrix (continued)
Key Company Profiles
Key Company Profiles (continued)
Key Company Profiles (continued)
Key Company Product Matrix
Funding Trends
Mergers & Acquisitions and Partnerships
Mergers & Acquisitions and Partnerships (continued)
Growth Opportunity 1—Use AI-ML on Liquid Biopsy Data to Identify Novel Biomarkers
Growth Opportunity 1—Use AI-ML on Liquid Biopsy Data to Identify Novel Biomarkers (continued)
Growth Opportunity 2—Expand Liquid Biopsy NGS as CDx through Co-development Partnerships
Growth Opportunity 2—Expand Liquid Biopsy NGS as CDx through Co-development Partnerships (continued)
Growth Opportunity 3—cfDNA Methylation as a Pan-cancer Screening Biomarker
Growth Opportunity 3—cfDNA Methylation as a Pan-cancer Screening Biomarker (continued)
Growth Opportunity 4—Liquid Biopsy for Early Neurodegenerative Disease Detection
Growth Opportunity 4—Liquid Biopsy for Early Neurodegenerative Disease Detection (continued)
Growth Opportunity 5—Comprehensive Cancer Profiling to Improve Cancer Management for Hospitals and Laboratories
Growth Opportunity 5—Comprehensive Cancer Profiling to Improve Cancer Management for Hospitals and Laboratories (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures
- Liquid Biopsy Market: Key Growth Metrics, United States, 2020
- Liquid Biopsy Market: Growth Drivers, United States, 2021–2025
- Liquid Biopsy Market: Growth Restraints, United States, 2021–2025
- Liquid Biopsy Market: Revenue Forecast, United States, 2019–2025
- Liquid Biopsy Market: Revenue Forecast by Therapy, United States, 2019–2025
- Liquid Biopsy Market: Revenue Forecast by Oncology Product/Service Type, United States, 2019–2025
- Liquid Biopsy Market: Revenue Forecast by NIPT Product/Service Type, United States, 2019–2025
- Liquid Biopsy Market: Revenue Forecast for Other Products/Services, United States, 2019–2025
- Liquid Biopsy Market: Competitive Environment, United States, 2020
- Liquid Biopsy Market: Revenue Share of Top Participants, United States, 2020
- Liquid Biopsy Market: Revenue Share of Top Participants—Oncology Therapy, United States, 2020
- Liquid Biopsy Market: Revenue Share of Top Participants—NIPT Therapy, United States, 2020
- Oncology Therapy Segment: Key Growth Metrics, United States, 2020
- Oncology Therapy Segment: Revenue Forecast, United States, 2019–2025
- Non-oncology Therapy Segment: Key Growth Metrics, United States, 2020
- Non-oncology Therapy Segment: Revenue Forecast, United States, 2019–2025
- Liquid Biopsy VC Deal Activity, Global, 2016–H1 2021
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-car...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| List of Charts and Figures | Liquid Biopsy Market: Key Growth Metrics, United States, 2020~ Liquid Biopsy Market: Growth Drivers, United States, 2021–2025~ Liquid Biopsy Market: Growth Restraints, United States, 2021–2025~ Liquid Biopsy Market: Revenue Forecast, United States, 2019–2025~ Liquid Biopsy Market: Revenue Forecast by Therapy, United States, 2019–2025~ Liquid Biopsy Market: Revenue Forecast by Oncology Product/Service Type, United States, 2019–2025~ Liquid Biopsy Market: Revenue Forecast by NIPT Product/Service Type, United States, 2019–2025~ Liquid Biopsy Market: Revenue Forecast for Other Products/Services, United States, 2019–2025~ Liquid Biopsy Market: Competitive Environment, United States, 2020~ Liquid Biopsy Market: Revenue Share of Top Participants, United States, 2020~ Liquid Biopsy Market: Revenue Share of Top Participants—Oncology Therapy, United States, 2020~ Liquid Biopsy Market: Revenue Share of Top Participants—NIPT Therapy, United States, 2020~ Oncology Therapy Segment: Key Growth Metrics, United States, 2020~ Oncology Therapy Segment: Revenue Forecast, United States, 2019–2025~ Non-oncology Therapy Segment: Key Growth Metrics, United States, 2020~ Non-oncology Therapy Segment: Revenue Forecast, United States, 2019–2025~ Liquid Biopsy VC Deal Activity, Global, 2016–H1 2021~ |
| Author | Amol Dilip Jadhav |
| Industries | Healthcare |
| WIP Number | K695-01-00-00-00 |
| Keyword 1 | liquid biopsy |
| Keyword 2 | cancer biopsy |
| Keyword 3 | LBx Market |
| Is Prebook | No |
| GPS Codes | 9600-B1,9562-B1,9568-B1,9611-B1,9627-B1 |